Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: Differences with mianserin and clozapine

Journal of Neurochemistry

Volumn 88, Issue 4, 2004, Pages 917-927

  Valentini, V ^a   Frau, R ^a   Di Chiara, G ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Antidepressants; Clozapine; Cortex; Microdialysis; Monoamines

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; COTRANSPORTER; DESIPRAMINE; DOPAMINE; DOPAMINE UPTAKE INHIBITOR; MIANSERIN; MORPHOLINE DERIVATIVE; NORADRENALIN TRANSPORTER; NORADRENALINE TRANSPORTER; OXIDOPAMINE; PIPERAZINE DERIVATIVE; REBOXETINE; SEROTONIN 2 ANTAGONIST; SEROTONIN ANTAGONIST; VANOXERINE;

ANALYSIS OF VARIANCE; ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; COMPARATIVE STUDY; CONTROLLED STUDY; DIALYSATE; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; DRUG INTERACTION; DRUG MECHANISM; EXTRACELLULAR SPACE; HISTOLOGY; INJURY; MALE; METABOLISM; MICRODIALYSIS; NERVE TRACT; NONHUMAN; OCCIPITAL CORTEX; PARIETAL LOBE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RAT STRAIN; TIME;

ANIMALIA;

EID: 1042278017     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02238.x     Document Type: Article

References (48)

1. Berger B. (1977) Histochemical identification and localization of dopaminergic axons in rat and human cerebral cortex. Adv. Biochem. Psychopharmacol. 16, 13-20.
2. Berger B. (1992) Dopaminergic innervation of the frontal cerebral cortex. Evolutionary trends and functional implications. Adv. Neurol. 57, 525-544.
3. Berger B., Tassin J. P., Blanc G., Moyne M. A. and Thierry A. M. (1974) Histochemical confirmation for dopaminergic innervation of the rat cerebral cortex after destruction of the noradrenergic ascending pathways. Brain Res. 81, 332-337.
4. Berger B., Thierry A. M., Tassin J. P. and Moyne M. A. (1976) Dopaminergic innervation of the rat prefrontal cortex: a fluorescence histochemical study. Brain Res. 106, 133-145.
5. Berger B., Doucet G. and Descarries L. (1988) Density of the dopamine innervation in rat cerebral cortex after neonatal 6-hydroxydopamine or adult stage DSP-4 noradrenaline denervations: a quantitative radioautographic study. Brain Res. 441, 260-268.
6. Berger B., Gaspar P. and Verney C. (1991) Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends Neurosci. 14, 21-27.
7. Brunello N., Masotto C., Steardo L., Markstein R. and Racagni G. (1995) New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology 13, 177-213.
8. Bungay P. M., Dedrick R. L., Fox E. and Balis F. M. (2001) Probe calibration in transient microdialysis in vivo. Pharm. Res. 18, 361-366.
9. Carboni E., Tanda G. L., Frau R. and Di Chiara G. (1990) Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem. 55, 1067-1070.
10. Chen J. P., Ruan D., Paredes W. and Gardner E. L. (1992) Effects of acute and chronic clozapine on dopaminergic function in medial prefrontal cortex of awake, freely moving rats. Brain Res. 571, 235-241.
11. Conn P. J. and Sanders-Bush E. (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors. J. Pharmacol. Exp. Ther. 242, 552-557.
12. De Boer T., Nefkens F. and Van Helvoirt A. (1994) The alpha 2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo. Eur. J. Pharmacol. 253, R5-R6.
13. Devoto P., Flore G., Pani L. and Gessa G. L. (2001) Evidence for corelease of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol. Psychiatry 6, 657-664.
14. Devoto P., Flore G., Vacca G., Pira L., Arca A., Casu M. A., Pani L. and Gessa G. L. (2003) Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic. Psychopharmacology (Berl) 167, 79-84.
15. Di Chiara G., Tanda G. L., Frau R. and Carboni E. (1992) Heterologous monoamine reuptake: lack of transmitter specificity of neuron-specific carriers. Neurochem. Int. 20, 231S-235S.
16. Di Chiara G., Tanda G., Frau R. and Carboni E. (1993) On the preferential release of dopamine in the nucleus accumbens by amphetamine: further evidence obtained by vertically implanted concentric dialysis probes. Psychopharmacology (Berl) 112, 398-402.
17. Di Chiara G., Loddo P. and Tanda G. (1999) Reciprocal changes in prefrontal and limbic dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress: implications for the psychobiology of depression. Biol. Psychiatry 46, 1624-1633.
18. Drevets W. C., Ongur D. and Price J. L. (1998) Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol. Psychiatry 3, 220-221.
19. Gobert A., Rivet J. M., Cistarelli L., Melon C. and Millan M. J. (1997) Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats. J. Neurochem. 69, 2616-2619.
20. Gobert A., Rivet J. M., Audinot V., Newman-Tancredi A., Cistarelli L. and Millan M. J. (1998) Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release. Neuroscience 84, 413-429.
21. Grenhoff J., Nisell M., Ferre S., Aston-Jones G. and Svensson T. H. (1993) Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J. Neural Transm. Gen. Sect. 93, 11-25.
22. Grenhoff J., North R. A. and Johnson S. W. (1995) Alpha 1-adrenergic effects on dopamine neurons recorded intracellularly in the rat midbrain slice. Eur. J. Neurosci. 7, 1707-1713.
23. Gresch P. J., Sved A. F., Zigmond M. J. and Finlay J. M. (1995) Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J. Neurochem. 65, 111-116.
24. Hertel P., Nomikos G. G., Iurlo M. and Svensson T. H. (1996) Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain. Psychopharmacology (Berl) 124, 74-86.
25. Hertel P., Nomikos G. G. and Svensson T. H. (1999) Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level. Eur. J. Pharmacol. 371, 153-158.
26. Invernizzi R. W., Parini S., Sacchetti G., Fracasso C., Caccia S., Annoni K. and Samanin R. (2001) Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha (2)-adrenoceptors in the prefrontal cortex. Br. J. Pharmacol. 132, 183-188.
27. Lindvall O., Bjorklund A. and Divac I. (1977) Organization of mesencephalic dopamine neurons projecting to neocortex and septum. Adv. Biochem. Psychopharmacol. 16, 39-46.
28. Lindvall O., Bjorklund A. and Divac I. (1978) Organization of catecholamine neurons projecting to the frontal cortex in the rat. Brain Res. 142, 1-24.
29. Linner L., Endersz H., Ohman D., Bengtsson F., Schalling M. and Svensson T. H. (2001) Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex. J. Pharmacol. Exp. Ther. 297, 540-546.
30. Millan M. J., Gobert A., Rivet J. M., Adhumeau-Auclair A., Cussac D., Newman-Tancredi A., Dekeyne A., Nicolas J. P. and Lejeune F. (2000a) Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram. Eur J. Neurosci. 12, 1079-1095.
31. Millan M. J., Lejeune F. and Gobert A. (2000b) Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents. J. Psychopharmacol. 14, 114-138.
32. Moghaddam B. (1994) Preferential activation of cortical dopamine neurotransmission by clozapine: functional significance. J. Clin. Psychiatry 55, 27-29.
33. Moghaddam B. and Bunney B. S. (1990) Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J. Neurochem. 54, 1755-1760.
34. Moron J. A., Brockington A., Wise R. A., Rocha B. A. and Hope B. T. (2002) Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J. Neurosci. 22, 389-395.
35. Mundorf M. L., Joseph J. D., Austin C. M., Caron M. G. and Wightman R. M. (2001) Catecholamine release and uptake in the mouse prefrontal cortex. J. Neurochem. 79, 130-142.
36. Nissbrandt H., Engberg G. and Pileblad E. (1991) The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra. Naunyn Schmiedebergs Arch. Pharmacol. 344, 16-28.
37. Paxinos G. and Watson C. (1998) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
38. Pozzi L., Invemizzi R., Cervo L., Vallebuona F. and Samanin R. (1994) Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. J. Neurochem. 63, 195-200.
39. Robbins T. W. (2000) From arousal to cognition: the integrative position of the prefrontal cortex. Prog. Brain Res. 126, 469-483.
40. Sacchetti G., Bernini M., Bianchetti A., Parini S., Invernizzi R. W. and Samanin R. (1999) Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain. Br. J. Pharmacol. 128, 1332-1338.
41. Tanda G. and Di Chiara G. (1998) A dopamine-mul opioid link in the rat ventral tegmentum, shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse. Eur. J. Neurosci. 10, 1179-1187.
42. Tanda G., Carboni E., Frau R. and Di Chiara G. (1994) Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology (Berl) 115, 285-288.
43. Tanda G., Bassareo V. and Di Chiara G. (1996) Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat. Psychopharmacology (Berl) 123, 127-130.
44. Volonte M., Monferini E., Cerutti M., Fodritto F. and Borsini F. (1997) BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex. J. Neurochem. 69, 182-190.
45. Weinberger D. R., Egan M. F., Bertolino A., Callicott J. H., Mattay V. S., Lipska B. K., Berman K. F. and Goldberg T. E. (2001) Prefrontal neurons and the genetics of schizophrenia. Biol. Psychiatry 50, 825-844.
46. Westerink B. H. (2002) Can antipsychotic drugs be classified by their effects on a particular group of dopamine neurons in the brain? Eur. J. Pharmacol. 455, 1-18.
47. Westerink B. H., De Boer P., De Vries J. B., Kruse C. G. and Long S. K. (1998) Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain. Eur. J. Pharmacol. 361, 27-33.
48. Westerink B. H., Kawahara Y., De Boer P., Geels C., De Vries J. B., Wikstrom H. V., Van Kalkeren A., Van Vliet B., Kruse C. G. and Long S. K. (2001) Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum. Eur. J. Pharmacol. 412, 127-138.